Ainos Articulates Its Platform Strategy to Digitize Smell as the Next Native AI Data Language

A Twin-Engine SmellTech Structure: Ainos on the Edge, ScentAI Scaling AI Intelligence

HOUSTON, TX / ACCESS Newswire / January 2, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) as we speak launched an announcement from Chairman, President and Chief Govt Officer Eddy Tsai, outlining the Firm’s long-term platform technique to digitize scent as a local knowledge language for synthetic intelligence, its execution priorities for 2026, and the complementary roles of Ainos and its wholly owned AI software program subsidiary, ScentAI Inc. (“ScentAI”), throughout the SmellTech platform – AI Nostril.

Ainos is executing a disciplined, long-term technique to rework scent from a sensory sign right into a structured knowledge language that synthetic intelligence programs can perceive, be taught from, and scale. Whereas AI has efficiently transformed textual content, photographs, and sound into computable tokens, scent stays one of many final main human senses not but systematically digitized. We imagine this represents a structurally important alternative within the evolution of AI.

Layered SmellTech Platform Structure
AI Nostril, our SmellTech platform, is designed as a layered and tightly built-in structure to assist scalability, knowledge consistency, and long-term platform sturdiness. Ainos is working on the fringe of the bodily world, designing, manufacturing, and deploying its AI Nostril sensing {hardware}. Ainos maintains management over sensor design, firmware, calibration, manufacturing processes, high quality assurance, and international certifications to make sure that scent knowledge generated throughout deployments is dependable, repeatable, and appropriate for large-scale AI coaching.

Rationale for the Twin-Engine Platform Design
Ainos is adopting a dual-engine platform structure primarily based on long-term design concerns slightly than organizational or short-term operational elements. Ainos believes that combining sensing, knowledge technology, and AI intelligence inside a single working construction might constrain scalability and long-term worth creation. By separating the sensing layer from the intelligence layer, the platform is designed to protect strategic flexibility, governance readability, and scalability as deployments broaden.

Structural Separation Between Ainos and ScentAI
Throughout the SmellTech platform, Ainos focuses completely on sensing {hardware}, bodily deployment, and knowledge technology, whereas ScentAI focuses on AI fashions, knowledge abstraction, and intelligence supply. The 2 entities is not going to compete on the product or buyer degree. As a substitute, they are going to function as complementary layers inside a unified platform structure, decreasing function ambiguity and long-term operational friction.

Scent Language Mannequin (SLM)
ScentAI is positioned to develop the Scent Language Mannequin (SLM), the core AI system of the SmellTech platform. SLM is designed to categorise, contextualize, and allow cross-environment studying of scent knowledge in a structured, trainable format. By means of SLM, we anticipate scent to develop into an AI-native knowledge asset that may be scaled and monetized by enterprise APIs, SaaS choices, and mannequin licensing, whereas Ainos retains possession of its core datasets and AI fashions.

2026 Execution Priorities
In 2026, Ainos is dedicated to driving scaled deployment, with an preliminary give attention to superior semiconductor manufacturing and robotic functions. These environments demand excessive sensing precision, reliability, and steady knowledge technology, making them well-suited for accelerating knowledge accumulation and AI mannequin coaching. We view these functions as a powerful place to begin in our growth to the economic market, with the AI Nostril platform positioned to increase nicely past these preliminary markets as deployment scales.

Lengthy-Time period Platform Worth and Knowledge Flywheel
As AI Nostril deployments broaden, the amount and variety of scent knowledge improve, driving steady enchancment of the Scent Language Mannequin. This suggestions loop between sensing, knowledge accumulation, and mannequin evolution helps the event of recurring, intelligence-driven income streams over time, whereas Ainos maintains management over the sensing layer that anchors the platform.

About Ainos, Inc.
Ainos, Inc. (NASDAQ:AIMD) is a dual-platform AI and biotech firm pioneering smelltech and immune therapeutics. Its AI Nostril platform and scent language mannequin (SLM) digitize scent into Scent ID, a machine-readable knowledge format, powering clever sensing throughout robotics, good factories, and healthcare. The corporate additionally develops VELDONA^®, a low-dose oral interferon focusing on uncommon, autoimmune, and infectious illnesses. Ainos, a fusion of “AI” and “Nostril,” is redefining machine notion for the sensory age. To be taught extra, go to https://www.ainos.com. Observe Ainos on X, previously often called Twitter, (@AinosInc) and LinkedIn to remain up-to-date.

Ahead-Trying Statements
Sure statements on this press launch are forward-looking statements throughout the that means of Part 27A of the Securities Act of 1933, as amended, and Part 21E of the Securities Trade Act of 1934, as amended. All statements aside from statements of historic reality are forward-looking statements. Ahead-looking statements are primarily based on administration’s present assumptions and expectations of future occasions and developments, which have an effect on or might have an effect on the Firm’s enterprise, technique, operations or monetary efficiency, and precise outcomes and different occasions might differ materially from these expressed or implied in such statements resulting from quite a few dangers and uncertainties. Ahead-looking statements are inherently topic to dangers and uncertainties, a few of which can’t be predicted or quantified. There are a variety of essential elements that would trigger precise outcomes, developments, enterprise choices or different occasions to vary materially from these contemplated by the forward-looking statements on this press launch. These elements embody, amongst different issues, our expectation that we’ll incur web losses for the foreseeable future; our means to develop into worthwhile; our means to boost further capital to proceed our product growth; our means to precisely predict our future working outcomes; our means to advance our present or future product candidates by medical trials, acquire advertising approval and finally commercialize any product candidates we develop; the flexibility to acquire and preserve regulatory approval of our product candidates; delays in finishing the event and commercialization of our present and future product candidates; growing and commercializing further merchandise, together with diagnostic testing gadgets; our means to compete within the market; compliance with relevant legal guidelines, laws and tariffs, and elements described within the Threat Components part of our public filings with the Securities and Trade Fee (SEC). As a result of forward-looking statements are inherently topic to dangers and uncertainties, you shouldn’t depend on these forward-looking statements as predictions of future occasions. These forward-looking statements communicate solely as of the date of this press launch and, besides to the extent required by relevant regulation, the Firm undertakes no obligation to replace or revise these statements, whether or not on account of any new data, future occasions and developments or in any other case.

Investor Relations Contact
Feifei Shen
E mail: [email protected]

SOURCE: Ainos, Inc.